Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders ...

The conference will also address the adoption of smart and sustainable city models that focus on multi-resource development ...

Jacksonville gets proposal to build new jail from firms involved in EverBank Field design and Duval County Public Schools ...

Research and Development Expenses: Research and development expenses were $13.7 million for the first quarter of 2025, ...

C4IR Telangana Life Sciences Skilling Program collaboration with TLS, industry, and academia to bridge skilled workforce gap.

KCFD’s dated facilities, some of which are approaching 100 years old, are largely in what union and department representatives called “poor” and “deplorable” conditions.

Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated Phase 1 topline data anticipated this quarter On track to initiate Phase 2a pr ...

Record company Q1 revenue, increased 43.2% year over year to $116.5 millionGross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year STAFFORD, Texas, May 12, 2025 ...

The hustle and bustle of New York City set the scene for ENR’s conversation with this year’s National Top 20 Under 40 winners.

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

As a commuter school situated relatively far from most subway lines, hundreds of Queens College students rely on the MTA’s bus offerings to get to and from campus every day. From the east and ...